tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Lee, 395 are a BUY (72.48%), 14 are a SELL (2.57%), 136 are a HOLD (24.95%).
Analyst James Lee, currently employed at MIZUHO, carries an average stock price target met ratio of 58.11% that have a potential upside of 40.03% achieved within 160 days.
James Lee’s has documented 1,078 price targets and ratings displayed on 49 stocks. The coverage is on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.
Most recent stock forecast was given on JD, JD.com Adr at 07-Mar-2025.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$112
$-16.8 (-13.04%)
$124
6 days ago
(21-Mar-2025)
3/4 (75%)
$-16.8 (-13.04%)
33
Buy
$200
$71.2 (55.28%)
$195
13 days ago
(14-Mar-2025)
2/7 (28.57%)
$77.14 (62.79%)
294
Hold
$185
$56.2 (43.63%)
$135
17 days ago
(10-Mar-2025)
7/11 (63.64%)
$52.85 (39.99%)
55
Hold
$185
$56.2 (43.63%)
17 days ago
(10-Mar-2025)
4/5 (80%)
$52.85 (39.99%)
61
Buy
$200
$71.2 (55.28%)
$160
1 months 9 days ago
(18-Feb-2025)
9/14 (64.29%)
$39.4 (24.53%)
167
Which stock is James Lee is most bullish on?
Which stock is James Lee is most reserved on?
What Year was the first public recommendation made by James Lee?
